Venoms to Drugs: Venom As a Source for the Development of Human Therapeutics - Couverture rigide

 
9781849736633: Venoms to Drugs: Venom As a Source for the Development of Human Therapeutics

Synopsis

An exciting volume that provides a comprehensive and up-to-date review on the potential of peptides and proteins from animal venoms as human therapeutics.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Professor Glenn King has been working on animal venoms since 1996.He has extensive experience in the discovery, production, and structural and functional characterization of venom proteins, and is intimately aware of the issues surrounding their development as drugs and insecticides. In 2006, Professor King founded an agricultural biotechnology company, Vestaron Corporation, that is developing spider-venom peptides discovered in the lab as bioinsecticides.His current research is largely focussed on the development of venom peptides as analgesics for the treatment of chronic pain.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.